Literature DB >> 2608569

Cirrhosis in partial lipodystrophy.

D A Robertson1, R Wright.   

Abstract

A patient with partial lipodystrophy, fatty liver and cirrhosis, and autoimmune thyroid disease is described. Treatment with thyroxine led to partial improvement in the hepatic abnormality.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2608569      PMCID： PMC2429293          DOI： 10.1136/pgmj.65.763.318

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  3 in total

1.  Metabolic studies in familial partial lipodystrophy of the lower trunk and extremities.

Authors:  M B Davidson; R T Young
Journal:  Diabetologia       Date:  1975-12       Impact factor: 10.122

2.  Changes in excretion of intestinal cholesterol and sterol digitonides in hyper and hypothyroidism.

Authors:  M FRIEDMAN; S O BYERS; R H ROSENMAN
Journal:  Circulation       Date:  1952-05       Impact factor: 29.690

3.  The complement abnormalities of lipodystrophy.

Authors:  J G Sissons; R J West; J Fallows; D G Williams; B J Boucher; N Amos; D K Peters
Journal:  N Engl J Med       Date:  1976-02-26       Impact factor: 91.245
  3 in total
  3 in total

Review 1.  Phenotypic and Genetic Characteristics of Lipodystrophy: Pathophysiology, Metabolic Abnormalities, and Comorbidities.

Authors:  Baris Akinci; Rasimcan Meral; Elif Arioglu Oral
Journal:  Curr Diab Rep       Date:  2018-11-08       Impact factor: 4.810

Review 2.  Pathogenesis and management issues for non-alcoholic fatty liver disease.

Authors:  Marko Duvnjak; Ivan Lerotić; Neven Barsić; Vedran Tomasić; Lucija Virović Jukić; Vedran Velagić
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

3.  Visceral fat does not contribute to metabolic disease in lipodystrophy.

Authors:  N Malandrino; J C Reynolds; R J Brychta; K Y Chen; S Auh; A M Gharib; M Startzell; E K Cochran; R J Brown
Journal:  Obes Sci Pract       Date:  2019-01-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.